Session Information
Session Type: Abstract Submissions (ACR)
Background/Purpose
Epidemiologic difference between European and Asian populations is observed in antineutrophil cytoplasmic antibody (ANCA) – associated vasculitis (AAV). Granulomatosis with polyangiitis (GPA) is prevalent in European populations, while microscopic polyangiitis (MPA) is common in Japanese. Genetic factors appear to contribute to the difference in epidemiology, which was supported by a recent genome-wide association study (GWAS) (Lyons et al., 2012). The GWAS indicated that GPA / proteinase 3 (PR3)-ANCA was associated with HLA-DP region, whereas MPA / myeloperoxidase (MPO) – ANCA was associated with HLA-DQ region. These results were consistent with the previous studies showing the association of GPA with HLA-DPB1*04:01 in European populations, as well as our study that reported HLA-DRB1*09:01-DQB1*03:03 haplotype was associated with MPA in Japanese (Tsuchiya et al., 2006). However, due to the rarity of AAV, contribution of HLA-DPB1 to either MPA or GPA has not been reported in a Japanese population.
In this study, by means of multicenter collaborative study in Japan, we investigated whether HLA-DPB1 is associated with susceptibility to AAV in Japanese, and whether the differences in HLA-DPB1 allele frequency can in part account for the population difference in AAV subsets.
Methods
Association of HLA-DPB1 was examined in 356 Japanese patients with AAV and 580 healthy controls. According to the European Medicines Agency algorithm, 220 patients were classified as MPA, 69 as GPA and 35 as eosinophilic granulomatosis with polyangiitis (EGPA). Among the patients, 300 were positive for MPO-ANCA and 41 were positive for PR3-ANCA. HLA-DPB1 typing was performed by the PCR-SSOP (Sequence Specific Oligonucleotide probes) method.
Results
HLA-DPB1*04:01, which was reported to be a risk allele to GPA in European populations, is decreased in MPA (dominant model, P=0.031, odds ratio [OR] 0.53), and more strikingly in MPO-ANCA positive AAV (P=0.0026, OR 0.44). DPB1*05:01 was also decreased in MPA (allele model, P=0.0063, OR 0.72). On the other hand, DPB1*04:01 was increased in PR3-ANCA positive AAV (allele model, P=0.010, OR 2.38). Interestingly, although significant association was not detected in GPA as a whole, DPB1*04:01 was significantly increased when only PR3-ANCA positive GPA was examined (P=5.7E-4, OR 3.18), but not in MPO-ANCA positive GPA.
Conclusion
This study demonstrated that DPB1*04:01 is a risk allele to PR3-ANCA positive AAV also in the Japanese population. In contrast. DPB1*04:01 was protective against MPO-ANCA positive AAV. In view of the population difference in the DPB1*04:01 allele frequency in the Japanese (6.1%) and in the European populations (42.5% in USA, The Allele Frequency Net Database), DPB1*04:01 may in part account for the epidemiological difference in the prevalence of MPO-ANCA and PR3-ANCA positive AAV, in addition to the DRB1*09:01-DQB1*03:03 haplotype.
n |
Allele frequency |
P |
OR(95%CI) |
Carrier frequency |
P |
OR(95%CI) |
||
MPA |
220 |
16(0.036) |
0.050 |
0.58(0.33-1.00) |
15(0.068) |
0.031 |
0.53(0.30-0.95) |
|
GPA |
69 |
12(0.087) |
0.24 |
1.46(0.77-2.76) |
10(0.145) |
0.56 |
1.23(0.60-2.52) |
|
MPO+ GPA |
39 |
2(0.026) |
0.32 |
0.40(0.10-1.68) |
|
2(0.051) |
0.30 |
0.39(0.09-1.67) |
PR3+ GPA |
32 |
11(0.172) |
5.7X10-4 |
3.18(1.65-6.15) |
9(0.281) |
0.0084 |
2.85(1.31-6.21) |
|
MPO+ AAV |
300 |
18(0.030) |
0.0046 |
0.47(0.28-0.79) |
17(0.057) |
0.0026 |
0.44(0.26-0.75) |
|
PR3+ AAV |
41 |
11(0.134) |
0.010 |
2.38(1.23-4.60) |
9(0.220) |
0.066 |
2.05(0.95-4.41) |
|
Healthy control |
580 |
71(0.061) |
70(0.121) |
Disclosure:
A. Kawasaki,
None;
M. Hidaka,
None;
N. Hasebe,
None;
K. E. Sada,
None;
S. Kobayashi,
None;
H. Yamada,
None;
H. Furukawa,
None;
K. Yamagata,
None;
T. Sumida,
None;
N. Miyasaka,
None;
S. Tohma,
None;
S. Ozaki,
None;
S. Matsuo,
None;
H. Hashimoto,
None;
H. Makino,
None;
M. Harigai,
None;
N. Tsuchiya,
None.
« Back to 2014 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/hla-dpb10401-confers-risk-for-pr3-anca-positive-anca-associated-vasculitis-aav-but-protects-against-mpo-anca-positive-aav-in-a-japanese-population/